Related Experiment Video
Updated: Jan 24, 2026

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
Published on: August 18, 2023
Celastrus orbiculatus Extracts Inhibit Human Hepatocellular Carcinoma Growth by Targeting mTOR Signaling Pathways
Ya-Yun Qian1,2,3, Wen-Yuan Li4, Yan Yan4
1Institute of Traditional Chinese Medicine and Western Medicine, School of Medicine, Yangzhou University, Yangzhou, 225009, Jiangsu Province, China. yyqian@yzu.edu.cn.
Objective:
To characterize the molecular mechanism underlying the antineoplastic activity of Celastrus orbiculatus Thunb. extracts (COE).
Methods:
The human hepatocellular carcinoma HepG2 cells with mammalian target of rapamycin (mTOR) knockdown expressed (HepG2/mTOR) were constructed using molecular biological technology. In vitro, the HepG2/mTOR- cells were treated with COE at various concentrations (10, 20, 40, 80, 160 and 320 µ g/mL). Cell viability was determined using 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assays. According to the half-maximal inhibitory concentration (IC50) value (140 mg/L), the concentrations of COE in the subsequent experiment was set to alleviate cytotoxicity. The HepG2/mTOR- cells were divided into 5 groups: negative control (untreated), COE treatment groups (40, 80, 120 mg/L COE) and positive control group (cisplatin, DDP, 2 mg/L), respectively. Wild-type HepG2 cells were used as a blank control. The effects of COE on the cell apoptosis were analyzed by flow cytometry and transmission electronic microscopy (TEM), respectively. The protein expression levels of mTOR signal pathways were determined by Western blotting. In vivo, HepG2/mTOR- cells (2 × 106 cell/mice) were subcutaneously injected into the right flank of nude mice. Thirty-six female nude mice were randomly assigned to 6 groups according to body weight (6 mice per group) as follows: solvent vehicle control, Banmao Capsule treated group (BM, 195 mg/kg), Tegafur, Gimeracil and Oteracil Potassium Capsules (10 mg/kg) treated group, and different dosages of COE (10, 20, 40 mg/kg) groups. Tumor growth was monitored and immunohistochemical staining was used to examine the expression of apoptosis-related proteins in tumor tissues.
Results:
COE inhibited the proliferation significantly in a concentration-dependent manner in HepG2/mTOR- cells (P<0.01). COE significantly induced the apoptosis of HepG2/mTOR- cells (P<0.01), and the apoptotic bodies can be observed under TEM. COE significantly inhibits the proteins expression of mTOR-related signal pathways. In vivo, COE significantly inhibited tumor growth in nude mice (P<0.01). Moreover, the results showed that COE down-regulated the expression of Bcl-2 and Bcl-xL, and up-regulated the levels of Bax and caspase-3 protein (P<0.01).
Conclusion:
COE was a potential chemotherapeutic drug in HCC treatments via targeting mTOR signal pathway.
Insights
Celastrus orbiculatus Thunb. extracts (COE) show potential as a chemotherapeutic agent for hepatocellular carcinoma (HCC). COE effectively inhibits cancer cell proliferation and tumor growth by targeting the mTOR pathway.
Area of Science:
- Pharmacology
- Molecular Biology
- Oncology
Background:
- Hepatocellular carcinoma (HCC) remains a significant global health challenge.
- Understanding the molecular mechanisms of novel antineoplastic agents is crucial for effective cancer treatment.
- Celastrus orbiculatus Thunb. extracts (COE) have demonstrated potential therapeutic properties.
Purpose of the Study:
- To elucidate the molecular mechanisms behind the antineoplastic activity of Celastrus orbiculatus Thunb. extracts (COE).
- To evaluate the efficacy of COE in inhibiting hepatocellular carcinoma cell growth and tumor progression.
- To investigate the role of the mTOR signaling pathway in COE's anti-cancer effects.
Main Methods:
- Construction of human hepatocellular carcinoma HepG2 cells with mammalian target of rapamycin (mTOR) knockdown (HepG2/mTOR⁻).
- In vitro assessment of COE's effects on cell viability, apoptosis (flow cytometry, TEM), and mTOR pathway protein expression (Western blotting).
- In vivo evaluation of COE's anti-tumor efficacy in nude mice xenograft models, with analysis of apoptosis-related protein expression via immunohistochemistry.
Main Results:
- COE significantly inhibited HepG2/mTOR⁻ cell proliferation and induced apoptosis in a dose-dependent manner.
- COE treatment led to the downregulation of mTOR-related signaling pathways.
- In vivo studies demonstrated that COE significantly inhibited tumor growth in nude mice and modulated apoptosis-related proteins (Bcl-2, Bax, caspase-3).
Conclusions:
- Celastrus orbiculatus Thunb. extracts (COE) exhibit significant antineoplastic activity against hepatocellular carcinoma.
- COE exerts its anti-cancer effects by targeting the mTOR signaling pathway.
- COE represents a potential chemotherapeutic drug for HCC treatment.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Insulin: The Receptor and Signaling Pathways

